Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes (Q36978835)

17 August 2017

1 reference

title

Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes (English)

1 reference

17 August 2017

1 reference

Philip Levy

1

1 reference

17 August 2017

16 April 2007

1 reference

MedGenMed : Medscape general medicine

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

2

1 reference

17 August 2017

12

1 reference

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

17 August 2017

1 reference

12 December 2020

Standards of medical care in diabetes--2007.

1 reference

12 December 2020

Medication adherence and associated hemoglobin A1c in type 2 diabetes

1 reference

12 December 2020

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

1 reference

12 December 2020

Can glycemic targets be achieved-- in particular with two daily injections of a mix of intermediate- and short-acting insulin?

1 reference

12 December 2020

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

12 December 2020

Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir

1 reference

12 December 2020

Novel insulins: expanding options in diabetes management

1 reference

12 December 2020

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

1 reference

12 December 2020

Variability of insulin absorption and insulin action

1 reference

12 December 2020

Oral Antidiabetic Agents

1 reference

12 December 2020

Before oral agents fail: the case for starting insulin early

1 reference

12 December 2020

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years

1 reference

12 December 2020

Spotlight on insulin detemir in type 1 and 2 diabetes mellitus

1 reference

12 December 2020

The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management--2000 update

1 reference

12 December 2020

Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach

1 reference

12 December 2020

Inhaled insulin: Exubera

1 reference

12 December 2020

Insulin glargine: an updated review of its use in the management of diabetes mellitus

1 reference

12 December 2020

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

12 December 2020

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Clinical practice. Initial management of glycemia in type 2 diabetes mellitus

1 reference

12 December 2020

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

1 reference

12 December 2020

Overcoming obstacles: new management options

1 reference

12 December 2020

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

12 December 2020

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

12 December 2020

Premixed insulin analogues for the treatment of diabetes mellitus

1 reference

12 December 2020

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

1 reference

12 December 2020

Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

1 reference

12 December 2020

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.

1 reference

12 December 2020

New therapies for type 2 diabetes based on glucagon-like peptide 1.

1 reference

12 December 2020

Dispelling myths and removing barriers about insulin in type 2 diabetes

1 reference

12 December 2020

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

12 December 2020

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

12 December 2020

A systematic review of adherence with medications for diabetes

1 reference

12 December 2020

Reproducibility and variability in the action of injected insulin

1 reference

12 December 2020

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

1 reference

12 December 2020

Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies

1 reference

12 December 2020

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.

1 reference

12 December 2020

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

1 reference

12 December 2020

Can we reduce hypoglycaemia with insulin detemir?

1 reference

12 December 2020

Making the transition from oral to insulin therapy

1 reference

12 December 2020

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

12 December 2020

Incretin mimetics and dipeptidyl peptidase-IV inhibitors: potential new therapies for type 2 diabetes mellitus

1 reference

12 December 2020

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

Early use of insulin in type 2 diabetes

1 reference

12 December 2020

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

1 reference

12 December 2020

Narrative review: a rational approach to starting insulin therapy

1 reference

12 December 2020

Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride

1 reference

12 December 2020

A critical appraisal of the role of insulin analogues in the management of diabetes mellitus

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes.

1 reference

12 December 2020

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues

1 reference

12 December 2020

Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Diabetes trends in the U.S.: 1990-1998.

1 reference

12 December 2020

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

1 reference

12 December 2020

Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.

1 reference

12 December 2020

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

12 December 2020

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

12 December 2020

Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes

1 reference

12 December 2020

Subcutaneous insulin: pharmacokinetic variability and glycemic variability

1 reference

12 December 2020

Identifiers

PubMed ID

17955068

1 reference

PubMed ID

17955068